For financial advisors, a good time to talk about sequence risk with clients is when markets are calm and clients are still ...
As our safety and pharmacovigilance month continues, Jabeen Ahmad discusses the challenges in evaluating the safety of new cancer treatments. Evaluating the safety of new cancer treatments in early ...